Patents by Inventor Jean M. Mathias

Jean M. Mathias has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7374870
    Abstract: Systems and methods treat plasma carrying contaminants and cellular matter that are capable of entraining contaminants. The systems and methods separate cellular matter from the plasma by filtration, thereby removing contaminants entrained within the cellular matter. The system and methods add to the plasma a photoactive material. The systems and methods emit radiation at a selected wavelength into the plasma to activate the photoactive material and thereby eradicate the contaminant that is free of entrainment by cellular matter.
    Type: Grant
    Filed: February 11, 2005
    Date of Patent: May 20, 2008
    Assignee: Fenwal, Inc.
    Inventors: Robert E. Herman, John Chapman, Chong-Son Sun, Jean M Mathias, Daniel F. Bischof
  • Patent number: 6855489
    Abstract: Systems and methods treat plasma carrying contaminants and cellular matter that are capable of entraining contaminants. The systems and methods separate cellular matter from the plasma by filtration, thereby removing contaminants entrained within the cellular matter. The system and methods add to the plasma a photoactive material. The systems and methods emit radiation at a selected wavelength into the plasma to activate the photoactive material and thereby eradicate the contaminant that is free of entrainment by cellular matter.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: February 15, 2005
    Assignee: Baxter International Inc.
    Inventors: Robert E. Herman, John Chapman, Chong-Son Sun, Jean M. Mathias, Veronique Mayaudon, Serge de Gheldere, Daniel F. Bischof
  • Patent number: 6190855
    Abstract: System and methods treat plasma carrying contaminants and cellular matter that are capable of entraining contaminants. The systems and methods separate cellular matter from the plasma by filtration, thereby removing contaminants entrained within the cellular matter. The system and methods add to the plasma a photoactive material. The systems and methods emit radiation at a selected wavelength into the plasma to activate the photoactive material and thereby eradicate the contaminant that is free of entrainment by cellular matter.
    Type: Grant
    Filed: October 28, 1996
    Date of Patent: February 20, 2001
    Assignee: Baxter International Inc.
    Inventors: Robert E. Herman, John Chapman, Chong-Son Sun, Jean M Mathias, Veronique Mayaudon, Serge de Gheldere, Daniel F. Bischof
  • Patent number: 5976884
    Abstract: Systems and methods treat biological fluids carrying contaminants by photoactivating materials mixed with the fluids. The systems and methods quantify the photoreactions that occur in a manner that permits correlation with clinical results.
    Type: Grant
    Filed: December 29, 1998
    Date of Patent: November 2, 1999
    Assignee: Baxter International Inc.
    Inventors: John R. Chapman, Jean M Mathias
  • Patent number: 5866074
    Abstract: A vessel holds a liquid content for exposure to prescribed light energy. The vessel has a region transparent to the prescribed light energy. The liquid content of the vessel includes a solution comprising a material undergoing reduction oxidation as a result of exposure to the prescribed light energy, and a reducing agent for the photoactive material. A device measures optical absorbance of the vessel and the liquid content. The device operates in a first instance to measure a first optical absorbance value before exposing the vessel and the liquid content to the prescribed light energy. The device also operates in a second instance to measure a second optical absorbance value after exposing the vessel and the liquid content to the prescribed light energy, to obtain a difference between the first and second optical absorbance values. The difference comprises an illumination characteristic for the vessel with respect to the prescribed light energy.
    Type: Grant
    Filed: December 20, 1996
    Date of Patent: February 2, 1999
    Assignee: Baxter International Inc.
    Inventors: John R. Chapman, Jean M. Mathias
  • Patent number: 4616760
    Abstract: A port and closure for a container is provided. The closure includes an interface layer for bonding the closure to the port. The bond strength of the interface layer to the closure is less than the bond strength of the interface layer to the port. The closure being removed from the port by delaminating the interface layer from the port.
    Type: Grant
    Filed: January 30, 1985
    Date of Patent: October 14, 1986
    Assignee: Baxter Travenol Laboratories, Inc.
    Inventors: Jean Kersten, Jean M. Mathias
  • Patent number: 4517090
    Abstract: There is disclosed herein a flow-through medical filter element which includes surface or depth filter media and a frame-like structure for supporting and positioning the media. The frame-like structure is a molded member which includes a ring-like inlet, a fluid-impervious terminal end spaced from the inlet and a plurality of rib-like members which extend between and interconnect the inlet end and terminal end. The inlet end includes internally-extending pleat-supporting projections and the terminal end has complementary externally-extending pleat-supporting shoulders. The frame-like structure is symmetrical about an axial plane which includes the mold parting line. The external shoulders are formed at angles which permits separation of a mold along the parting line and release of the part. The filter media also includes longitudinal pleats and is secured at its ends to the pleat-supporting projections associated with the inlet end and to the external pleat-supporting shoulders at the terminal end.
    Type: Grant
    Filed: April 6, 1984
    Date of Patent: May 14, 1985
    Assignee: Baxter Travenol Laboratories, Inc.
    Inventors: Jean Kersten, Jean M. Mathias
  • Patent number: D283919
    Type: Grant
    Filed: December 5, 1983
    Date of Patent: May 20, 1986
    Assignee: Baxter Travenol Laboratories, Inc.
    Inventors: Jean M. Mathias, Jean Kersten